Direct estimation of HDL-mediated cholesterol efflux capacity from serum

High-density lipoprotein mediated cholesterol efflux capacity (HDL-CEC) is a functional attribute that may have a protective role in atherogenesis. However, the estimation of HDL-CEC is based on in vitro cell assays that are laborious and hamper large-scale phenotyping. Here, we present a cost-effective high-throughput nuclear magnetic resonance (NMR) spectroscopy method to estimate HDL-CEC directly from serum. We applied the new method in a population-based study of 7,603 individuals including 574 who developed incident coronary heart disease (CHD) during 15 years of follow-up, making this the largest quantitative study for HDL-CEC. As estimated by NMR-spectroscopy, a 1-SD higher HDL-CEC was associated with a lower risk of incident CHD (hazards ratio 0.86; 95%CI 0.79-0.93, adjusted for traditional risk factors and HDL-C). These findings are consistent with published associations based on in vitro cell assays. These corroborative large-scale findings provide further support for a potential protective role of HDL-CEC in CHD, and substantiate this new method and its future applications.

Download data

• Downloaded 449 times
• Download rankings, all-time:
  • Site-wide: 49,292 out of 118,916
  • In epidemiology: 2,068 out of 4,677
• Year to date:
  • Site-wide: 93,423 out of 118,916
• Since beginning of last month:
  • Site-wide: 98,693 out of 118,916

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide